Covered recipient · General Payments record
GEORGE B RYCKMAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2021
$979.30
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $172.87 | 9 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $53.40 | 2 |
| Amgen Inc. | $42.27 | 2 |
| Novo Nordisk AS | $37.15 | 2 |
| Astellas Pharma US Inc | $14.02 | 1 |
| Janssen Pharmaceuticals, Inc | $13.84 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $12.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $28.62 | 09/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795912783 | CMS |
| AbbVie Inc. | $24.78 | 09/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795912787 | CMS |
| Amgen Inc. | $27.79 | 05/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825325825 | CMS |
| Amgen Inc. | $14.48 | 07/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825325829 | CMS |
| Astellas Pharma US Inc | $14.02 | 01/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 821524991 | CMS |
| Janssen Pharmaceuticals, Inc | $13.84 | 08/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788942513 | CMS |
| Novo Nordisk Inc | $17.72 | 04/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811170985 | CMS |
| Novo Nordisk Inc | $19.43 | 06/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811131939 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $12.19 | 05/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 820207651 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.